A New York couple who prefer to rent in the thick of things, even in a Hudson Valley town.
NYS Entity Status
NYS Filing Date
OCTOBER 22, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2013 - BIG TOWN LLC
AROUND THE WEB
- Living the Urban Life Upstate
By KIM VELSEY - Friday Jun 16, 2017
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Mets hope small-town fireballer can help big-time bullpen woes
By Mark W. Sanchez - Saturday Aug 12, 2017
In the middle of a loud Mets trade deadline, in which both Addison Reed and Lucas Duda were shipped out of town, was an unassuming 22-year-old, suddenly cast in a strange bit of a spotlight. Jamie Callahan, the top reliever the Mets extracted from Boston in exchange for Reed, was a rising arm from Dillon,...
- Trump slams NY Times story about Pence 2020 bid as ‘totally inept’
By Yaron Steinbuch - Monday Aug 7, 2017
President Trump slammed The New York Times early Monday for reporting that several Republicans — including Vice President Mike Pence — are angling for a presidential run in 2020. “The failing @nytimes, which has made every wrong prediction about me including my big election win (apologized), is totally inept!”
- Actor James Cromwell to report to jail for plant protest
Wednesday Jul 12, 2017
WAWAYANDA, N.Y. (AP) — Oscar-nominated actor James Cromwell is heading to jail in New York for blocking traffic to protest a power plant.A town judge sentenced the 77-year-old Cromwell and two fellow protesters to a week in the Orange County Jail for civil disobedience at the construction site of a 650-megawatt natural gas-fired power plant in December 2015.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]